|
1
|
Mark RJ, Poen JC, Tran LM, et al:
Angiosarcoma. A report of 67 patients and a review of the
literature. Cancer. 77:2400–2406. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cafiero F, Gipponi M, Peressini A, et al:
Radiation-associated angiosarcoma: diagnostic and therapeutic
implications: two case reports and a review of the literature.
Cancer. 77:2496–2502. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aust MR, Olsen KD, Lewis JE, et al:
Angiosarcomas of the head and neck: clinical and pathologic
characteristics. Ann Otol Rhinol Laryngol. 106:943–951. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fury MG, Antonescu CR, Van Zee KJ, et al:
A 14-year retrospective review of angiosarcoma: clinical
characteristics, prognostic factors and treatment outcomes with
surgery and chemotherapy. Cancer J. 11:241–247. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Young RJ, Brown NJ, Reed MW, et al:
Angiosarcoma. Lancet Oncol. 11:983–991. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fayette J, Martin E, Piperno-Neumann S, et
al: Angiosarcomas, a heterogeneous group of sarcomas with specific
behavior depending on primary site: a retrospective study of 161
cases. Ann Oncol. 18:2030–2036. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Therasse P, Arbuck SG, Eisenhauer EA, et
al: New guidelines to evaluate the response to treatment in solid
tumors. European Organization for Research and Treatment of Cancer,
National Cancer Institute of the United States, National Cancer
Institute of Canada. J Natl Cancer Inst. 92:205–216. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Trotti A, Colevas AD, Setser A, et al:
CTCAE v3.0: development of a comprehensive grading system for the
adverse effects of cancer treatment. Semin Radiat Oncol.
13:176–181. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Weiss SW and Goldblum JR: Enzinger and
Weiss’s Soft Tissue Tumors. 5th edition. Mosby Elsevier; St. Louis,
MO: 2008
|
|
10
|
Wolov RB, Sato N, Azumi N and Lack EE:
Intra-abdominal ‘angiosarcomatosis’ report of two cases after
pelvic irradiation. Cancer. 67:2275–2279. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Slingluff CL Jr, Hendrix J and Seigler HF:
Melanoma and cutaneous malignancies. Sabiston Textbook of Surgery:
The Biological Basis of Modern Surgical Practice. 16th edition.
Townsend CM Jr: W.B. Saunders Company; Philadelphia: pp. 487–510.
2001
|
|
12
|
Livingston SF and Kemperer P: Malignant
angiomas; with reference to the question of sarcoma due to roentgen
ray. Arch Pathol Lab Med. 1:899–910. 1926.
|
|
13
|
Jones EW: Malignant angioendothelioma of
the skin. Br J Dermatol. 76:21–39. 1964. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Obeng MK, Hernandez A, Dastgir A, et al:
Angiosarcoma of the scalp with calvarium involvement in a
50-year-old African-American man. J Natl Med Assoc. 96:1507–1512.
2004.PubMed/NCBI
|
|
15
|
Abraham JA, Hornicek FJ, Kaufman AM, et
al: Treatment and outcome of 82 patients with angiosarcoma. Ann
Surg Oncol. 14:1953–1967. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Naka N, Ohsawa M, Tomita Y, et al:
Angiosarcoma in Japan: a review of 99 cases. Cancer. 75:989–996.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pawlik TM, Paulino AF, McGinn CJ, et al:
Cutaneous angiosarcoma of the scalp: a multidisciplinary approach.
Cancer. 98:1716–1726. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lahat G, Dhuka AR, Lahat S, et al: Outcome
of locally recurrent and metastatic angiosarcoma. Ann Surg Oncol.
16:2502–2509. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Calonje E and Fletcher CDM: Vascular
tumors. Diagnostic Histopathology of Tumors. Fletcher CDM: 3rd
edition. Churchill Livingstone; pp. 41–76. 2007
|
|
20
|
Weiss SW, Lasota J and Miettinen MM:
Angiosarcoma of soft tissue. World Health Organization
Classification. Pathology and Genetics of Tumours of Soft Tissue
and Bone. Fletcher CDM, Unni KK and Mertens F: IARC Press; Lyon:
pp. 175–177. 2002
|
|
21
|
Ohsawa M, Naka N, Tomita Y, Kawamori D,
Kanno H and Aozasa K: Use of immunohistochemical procedures in
diagnosing angiosarcoma. Evaluation of 98 cases. Cancer.
75:2867–2874. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Naka N, Ohsawa M, Tomita Y, et al:
Prognostic factors in angiosarcoma: a multivariate analysis of 55
cases. J Surg Oncol. 61:170–176. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Van Glabbeke M, van Oosterom AT,
Oosterhuis JW, et al: Prognostic factors for the outcome of
chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185
patients treated with anthracycline containing first-line regimens
- a European Organization for Research and Treatment of Cancer Soft
Tissue and Bone Sarcoma Group Study. J Clin Oncol. 17:150–157.
1999.PubMed/NCBI
|
|
24
|
Budd GT: Management of angiosarcoma. Curr
Oncol Rep. 4:515–519. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mathew P, Vakar-Lopez F and Trocoso P:
Protracted remission of metastatic epithelioid angiosarcoma with
weekly infusion of doxorubicin, paclitaxel and cisplatin. Lancet
Oncol. 7:92–93. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eiling S, Lischner S, Busch JO, et al:
Complete remission of a radio-resistant cutaneous angiosarcoma of
the scalp by systemic treatment with liposomal doxorubicin. British
J Derm. 147:150–153. 2002. View Article : Google Scholar
|
|
27
|
Verdier E, Carvalo P, Young P, et al:
Lymphangiosarcoma treated with liposomal doxorubicin (Caelyx). Ann
Dermatol Venereol. 134:760–763. 2007.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Verweij J, Lee SM, Ruka W, et al:
Randomized phase II study of docetaxel versus doxorubicin in first-
and second-line chemotherapy for locally advanced or metastatic
soft tissue sarcomas in adults: a study of the european
organization for research and treatment of cancer soft tissue and
bone sarcoma group. J Clin Oncol. 18:2081–2086. 2000.PubMed/NCBI
|
|
29
|
Fraiman G, Ganti AK, Potti A and Mehdi S:
Angiosarcoma of the small intestine: a possible role for
thalidomide? Med Oncol. 20:397–402. 2003. View Article : Google Scholar
|
|
30
|
Ventura GJ and Roberts SC: Response of
metastatic angiosarcoma to thalidomide: Possible synergism with
radiation therapy. Proc Am Soc Clin Oncol. 19:575a2000.
|
|
31
|
Raina V, Sengar M, Shukla NK, et al:
Complete response from thalidomide in angiosarcoma after treatment
of breast cancer. J Clin Oncol. 25:900–901. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Koontz BF, Miles EF, Rubio MA, et al:
Preoperative radiotherapy and bevacizumab for angiosarcoma of the
head and neck: two case studies. Head Neck. 30:262–266. 2008.
View Article : Google Scholar
|
|
33
|
Agulnik M, Yarber JL, Okuno SH, et al: An
open-label, multicenter, phase II study of bevacizumab for the
treatment of angiosarcoma and epithelioid hemangioendotheliomas.
Ann Oncol. 24:257–263. 2013. View Article : Google Scholar
|
|
34
|
Maki RG, D’Adamo DR, Keohan ML, et al:
Phase II study of sorafenib in patients with metastatic or
recurrent sarcomas. J Clin Oncol. 27:3133–3140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhuang HQ and Yuan ZY: Process in the
mechanisms of endostatin combined with radiotherapy. Cancer Lett.
282:9–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
